John S. Pallies
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von John S. Pallies
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 21 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von John S. Pallies
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Hybritech, Inc.
 Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal | |
| XOMA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CURIS, INC. | Biotechnology | Director/Board Member | |
| TRAWS PHARMA, INC. | Biotechnology | Corporate Officer/Principal President | |
| XENCOR, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| NURIX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree | |
MPM Asset Management LLC
 MPM Asset Management LLC Financial ConglomeratesFinance Part of MPM BioImpact, Inc, MPM Asset Management LLC is a company that provides venture capital. The company is based in Boston, MA. | Financial Conglomerates | Corporate Officer/Principal Private Equity Investor | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Georgetown University | College/University | Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MUSC Foundation for Research Development | Director/Board Member Director/Board Member | ||
| DNAX Research, Inc. | Corporate Officer/Principal | ||
ACT Biotech, Inc.
 ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of California | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Founder Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Graduate Degree Masters Business Admin | |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Chairman | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ImmunoMet Therapeutics, Inc.
 ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Pharmaceuticals: Major | Director/Board Member | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Founder Director/Board Member | |
| ONCORUS, INC. | Biotechnology | Chairman Director/Board Member | |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Biotechnology | Founder Director/Board Member | |
Alliance for Clinical Research Excellence & Safety
 Alliance for Clinical Research Excellence & Safety Miscellaneous Commercial ServicesCommercial Services Alliance for Clinical Research Excellence & Safety is a non-governmental organization that builds, implements, and maintains comprehensive systems. The non-profit company is based in Cambridge, MA. The company was founded by Greg Koski. | Miscellaneous Commercial Services | Director/Board Member | |
| GOSSAMER BIO, INC. | Pharmaceuticals: Major | General Counsel | |
Redona Therapeutics, Inc.
 Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Aspen Neuroscience, Inc.
 Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Aspen Neuroscience, Inc. engages in the provision of neurological treatment services. It offers technologies for patient-specific induced pluripotent stem cell-based therapies. The company was founded by Jeanne Loring and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
| WEREWOLF THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
K36 Therapeutics, Inc.
 K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | Pharmaceuticals: Major | Director/Board Member | |
Photys Therapeutics, Inc.
 Photys Therapeutics, Inc. Medical SpecialtiesHealth Technology Photys Therapeutics, Inc. is a company based in Cambridge, MA that was founded by Longwood Fund and Dr. Amit Choudhary of Brigham and Women's Hospital and the Broad Institute of MIT and Harvard. The company is advancing phosphorylation inducing chimeric small molecules (PHICs), a proprietary new class of bifunctional medicines that direct and repair protein phosphorylation to treat a range of diseases including cancer, immune, metabolic, and rare diseases. PHICs enhance the pairing of specific kinases with disease target proteins, inducing precise phosphorylation at native and/or non-native sites, modulating key functions including activation, stabilization, trafficking, localization, phospho-antigen presentation, inactivation, degradation, and interactions of proteins. The company's approach unlocks diverse classes of targets, developing a new class of medicines for precise control of protein function. The company was founded by Amit Choudhary, David Steinberg, Edward Holson, Lizzie Ngo. David Steinberg has been the CEO since incorporation. | Medical Specialties | Director/Board Member Director/Board Member | |
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 50 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 35 |
| Consumer Services | 7 |
| Commercial Services | 5 |
| Finance | 3 |
| Retail Trade | 2 |
Operativ
| Director/Board Member | 212 |
| Corporate Officer/Principal | 72 |
| Independent Dir/Board Member | 63 |
| Chairman | 29 |
| Chief Executive Officer | 27 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Luke Evnin | 42 |
| Art Pappas | 42 |
| Ivor Royston | 30 |
| Arlene Morris | 28 |
| Lori Kunkel | 27 |
| Dennis Podlesak | 27 |
| Steven St. Peter | 26 |
| Briggs Morrison | 26 |
| Allan Shaw | 23 |
| Pamela Klein | 19 |
| Fabrice Egros | 18 |
| Joanna Horobin | 15 |
| Michael Metzger | 13 |
| Steven Fruchtman | 11 |
| Henry Chen | 11 |
- Börse
- Insiders
- John S. Pallies
- Unternehmensverbindungen
